129 related articles for article (PubMed ID: 35752351)
21. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.
Lazer G; Pe'er L; Farago M; Machida K; Mayer BJ; Katzav S
J Biol Chem; 2010 Jul; 285(30):23075-85. PubMed ID: 20457609
[TBL] [Abstract][Full Text] [Related]
22. Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele.
Wang Z; Feng Y; Bardeesy N; Wong KK; Liu XY; Ji H
PLoS One; 2012; 7(5):e37308. PubMed ID: 22606359
[TBL] [Abstract][Full Text] [Related]
23. Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation.
Xu J; Haigis KM; Firestone AJ; McNerney ME; Li Q; Davis E; Chen SC; Nakitandwe J; Downing J; Jacks T; Le Beau MM; Shannon K
Cancer Discov; 2013 Sep; 3(9):993-1001. PubMed ID: 23733505
[TBL] [Abstract][Full Text] [Related]
24. C-Raf is required for the initiation of lung cancer by K-Ras(G12D).
Karreth FA; Frese KK; DeNicola GM; Baccarini M; Tuveson DA
Cancer Discov; 2011 Jul; 1(2):128-36. PubMed ID: 22043453
[TBL] [Abstract][Full Text] [Related]
25. Vav1 GEF activity is required for T cell mediated allograft rejection.
Haubert D; Li J; Saveliev A; Calzascia T; Sutter E; Metzler B; Kaiser D; Tybulewicz VL; Weckbecker G
Transpl Immunol; 2012 Jun; 26(4):212-9. PubMed ID: 22456277
[TBL] [Abstract][Full Text] [Related]
26. Vav1 regulates MHCII expression in murine resting and activated B cells.
Jux B; Staratschek-Jox A; Penninger JM; Schultze JL; Kolanus W
Int Immunol; 2013 May; 25(5):307-17. PubMed ID: 23391492
[TBL] [Abstract][Full Text] [Related]
27. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
[TBL] [Abstract][Full Text] [Related]
28. Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma.
Mainardi S; Mijimolle N; Francoz S; Vicente-Dueñas C; Sánchez-García I; Barbacid M
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):255-60. PubMed ID: 24367082
[TBL] [Abstract][Full Text] [Related]
29. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.
Cortes JR; Filip I; Albero R; Patiño-Galindo JA; Quinn SA; Lin WW; Laurent AP; Shih BB; Brown JA; Cooke AJ; Mackey A; Einson J; Zairis S; Rivas-Delgado A; Laginestra MA; Pileri S; Campo E; Bhagat G; Ferrando AA; Rabadan R; Palomero T
Cell Rep; 2022 Apr; 39(3):110695. PubMed ID: 35443168
[TBL] [Abstract][Full Text] [Related]
31. A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation.
Kuhne MR; Ku G; Weiss A
J Biol Chem; 2000 Jan; 275(3):2185-90. PubMed ID: 10636924
[TBL] [Abstract][Full Text] [Related]
32. Vav1 mutations: What makes them oncogenic?
Farago M; Yarnitzky T; Shalom B; Katzav S
Cell Signal; 2020 Jan; 65():109438. PubMed ID: 31654719
[TBL] [Abstract][Full Text] [Related]
33. Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.
Minai-Tehrani A; Chang SH; Kwon JT; Hwang SK; Kim JE; Shin JY; Yu KN; Park SJ; Jiang HL; Kim JH; Hong SH; Kang B; Kim D; Chae CH; Lee KH; Beck GR; Cho MH
Cell Oncol (Dordr); 2013 Feb; 36(1):15-26. PubMed ID: 23070870
[TBL] [Abstract][Full Text] [Related]
34. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
35. The use of knockout mice reveals a synergistic role of the Vav1 and Rasgrf2 gene deficiencies in lymphomagenesis and metastasis.
Ruiz S; Santos E; Bustelo XR
PLoS One; 2009 Dec; 4(12):e8229. PubMed ID: 20011522
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis.
Robles-Valero J; Fernández-Nevado L; Lorenzo-Martín LF; Cuadrado M; Fernández-Pisonero I; Rodríguez-Fdez S; Astorga-Simón EN; Abad A; Caloto R; Bustelo XR
EMBO J; 2021 Nov; 40(22):e108125. PubMed ID: 34617326
[TBL] [Abstract][Full Text] [Related]
37. Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1.
Reynolds LF; de Bettignies C; Norton T; Beeser A; Chernoff J; Tybulewicz VL
J Biol Chem; 2004 Apr; 279(18):18239-46. PubMed ID: 14764585
[TBL] [Abstract][Full Text] [Related]
38. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
Yu T; Chen X; Zhang W; Liu J; Avdiushko R; Napier DL; Liu AX; Neltner JM; Wang C; Cohen D; Liu C
Cell Death Differ; 2016 Feb; 23(2):207-15. PubMed ID: 26113043
[TBL] [Abstract][Full Text] [Related]
39. VAV1 mutations contribute to development of T-cell neoplasms in mice.
Fukumoto K; Sakata-Yanagimoto M; Fujisawa M; Sakamoto T; Miyoshi H; Suehara Y; Nguyen TB; Suma S; Yanagimoto S; Shiraishi Y; Chiba K; Bouska A; Kataoka K; Ogawa S; Iqbal J; Ohshima K; Chiba S
Blood; 2020 Dec; 136(26):3018-3032. PubMed ID: 32992343
[TBL] [Abstract][Full Text] [Related]
40. Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway.
Park YH; Kim SU; Lee BK; Kim HS; Song IS; Shin HJ; Han YH; Chang KT; Kim JM; Lee DS; Kim YH; Choi CM; Kim BY; Yu DY
Antioxid Redox Signal; 2013 Aug; 19(5):482-96. PubMed ID: 23186333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]